SEGAL LLOYD MITCHELL (President and CEO) sold 4.6% of their position (5.14K shares) of REPARE THERAPEUTICS INC. on the open market
Open‑market sale worth $23.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/1/2024ACC: 0001415889-24-009629
Officer· President and CEO
Since Jun 2020
-5.14K
Net shares
Net seller
$23.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
5.14K disposed
Non-Derivative Transactions2
Common Shares
Indirect
Shares
−2.65K
Price / share
$4.62
Trade value
$12.24K
% of position
2.4%
3/28/2024
112.70K→110.05K
Common Shares
Indirect
Shares
−2.49K
Price / share
$4.63
Trade value
$11.53K
% of position
2.3%
4/1/2024
110.05K→107.56K
Total
Net shares
−5.14K
Net value
-$23.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 3/28/2024 | S · Sale | −2.65K | $4.62 | $12.24K | 2.4% | 112.70K | 110.05K |
| Common Shares Indirect | 4/1/2024 | S · Sale | −2.49K | $4.63 | $11.53K | 2.3% | 110.05K | 107.56K |
| Total | −5.14K | -$23.78K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Shares
DirectShares owned102.68K
Total
102.68K direct102.68K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 102.68K | Direct |
| Total | 102.68K | 102.68K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported